Immuron (IMRN) Current Assets (2016 - 2025)
Immuron (IMRN) posted quarterly Current Assets of $99780.0 for Q3 2025, down 32.24% year-over-year from $147263.4 in Q3 2024, and down 98.44% quarter-over-quarter from $6.4 million in Q2 2025.
Immuron (IMRN) Current Assets (2016 - 2025) Analysis & Trends
Immuron's Current Assets history runs 10 years deep, the most recent figure standing at $99780.0 for Q3 2025.
- In Q3 2025, Current Assets fell 32.24% year-over-year to $99780.0; the TTM figure through Sep 2025 stood at $99780.0 (down 32.24% YoY), while the FY2025 annual figure was $99780.0, down 32.24% from the prior year.
- Current Assets for Q3 2025 stood at $99780.0, down from $6.4 million in the prior quarter.
- The five-year high for Current Assets was $19.8 million in Q2 2021, with the low at $99780.0 in Q3 2025.
- The 5-year median for Current Assets is $11.5 million (2023), against an average of $9.9 million.
- The sharpest annual moves came in 2021 and 2023: Current Assets soared 6808.95% in 2021, then tumbled 99.21% in 2023.
- Immuron's Current Assets stood at $18.9 million in 2021, then retreated by 17.5% to $15.6 million in 2022, then plunged by 99.21% to $123340.8 in 2023, then soared by 6132.72% to $7.7 million in 2024, then sank by 98.7% to $99780.0 in 2025.
- Business Quant data shows IMRN's Current Assets at $99780.0 in Q3 2025, $6.4 million in Q2 2025, and $7.7 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.62 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.63 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.76 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 18.80 Bn |
| 10 | Immuron | 6.81 Mn | 6.78 Mn | - | 99,780.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | 99,780.03 |
| Jun 30, 2025 | 6.41 Mn |
| Dec 31, 2024 | 7.69 Mn |
| Sep 9, 2024 | 147,263.37 |
| Jun 30, 2024 | 9.71 Mn |
| Dec 31, 2023 | 123,340.82 |
| Sep 28, 2023 | 13.38 Mn |
| Aug 30, 2023 | 204,093.37 |
| Jun 30, 2023 | 13.64 Mn |
| Dec 31, 2022 | 15.55 Mn |
| Aug 31, 2022 | 16.46 Mn |
| Jun 30, 2022 | 16.96 Mn |
| Dec 31, 2021 | 18.85 Mn |
| Jun 30, 2021 | 19.83 Mn |
| Dec 31, 2020 | 272,856.21 |
| Sep 1, 2020 | 4.41 Mn |
| Jun 30, 2020 | 2.89 Mn |
| Dec 31, 2019 | 44,090.41 |
| Jun 30, 2019 | 4.68 Mn |
| Dec 31, 2018 | 7.05 Mn |